Biotech & MedTech News
-
Cardiol Therapeutics Reports Results of 2023 Annual General Meeting
June 29, 2023 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage…
-
Hemostemix Closes $403,539 of the Unit Private Placement
June 28, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it…
-
Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4:30 p.m. EDT
June 27, 2023 (Source) – Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) (“Cardiol” or the “Company”), a clinical-stage…
-
Zentek Provides Update on ZenARMOR(TM) Corrosion Protection Technology
June 22, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company…
-
Hemostemix’s Private Placement Use of Proceeds
June 21, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce the…
-
Hemostemix Announces Unit Private Placement
June 1, 2023 (Source) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce a…
-
Zentek Names Lisa Sim to the Board of Directors
June 1, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company…
-
Zentek and Pattern Energy to Collaborate on Icephobic Technology for Wind Turbine Industry
May 30, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company…
-
Zentek Announces Normal Course Issuer Bid
May 24, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSXV:ZEN), announces that, subject to regulatory approval, it…
-
Zentek Announces Transfer of the Albany Graphite Project to Subsidiary
May 23, 2023 (Source) – Zentek Ltd. (“Zentek” or the “Company”) (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company…
